What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Gene
Her primary areas of investigation include Internal medicine, Endocrinology, Breast cancer, Ovarian cancer and Prospective cohort study.
Her work in Internal medicine addresses subjects such as Oncology, which are connected to disciplines such as Adenocarcinoma.
Many of her studies on Endocrinology apply to Physiology as well.
Her study in Breast cancer is interdisciplinary in nature, drawing from both Sex hormone-binding globulin and Prolactin.
Her work deals with themes such as Rate ratio, Gynecology, Serous fluid and Genome-wide association study, which intersect with Ovarian cancer.
Her Prospective cohort study research includes themes of Epidemiology, Incidence, Cohort study, Case-control study and Disease.
Her most cited work include:
- Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk (951 citations)
- Plasma 25-Hydroxyvitamin D Levels and Risk of Incident Hypertension (719 citations)
- Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (406 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of study are Internal medicine, Ovarian cancer, Oncology, Prospective cohort study and Endocrinology.
Her study in Internal medicine concentrates on Cancer, Breast cancer, Case-control study, Odds ratio and Body mass index.
The various areas that Shelley S. Tworoger examines in her Breast cancer study include Quartile, Nested case-control study and Physiology.
Her Ovarian cancer study combines topics from a wide range of disciplines, such as Epidemiology, Serous fluid, Confidence interval, Gynecology and Proportional hazards model.
Her research investigates the link between Oncology and topics such as Single-nucleotide polymorphism that cross with problems in Cancer research.
The Prospective cohort study study combines topics in areas such as Incidence, Cohort study, Cohort and Risk factor.
She most often published in these fields:
- Internal medicine (97.21%)
- Ovarian cancer (61.08%)
- Oncology (49.39%)
What were the highlights of her more recent work (between 2017-2021)?
- Internal medicine (97.21%)
- Ovarian cancer (61.08%)
- Oncology (49.39%)
In recent papers she was focusing on the following fields of study:
Shelley S. Tworoger focuses on Internal medicine, Ovarian cancer, Oncology, Prospective cohort study and Hazard ratio.
Her study in Odds ratio, Cancer, Body mass index, Disease and Nurses' Health Study is done as part of Internal medicine.
Shelley S. Tworoger combines subjects such as Endocrinology and Type 2 diabetes with her study of Disease.
Shelley S. Tworoger has included themes like Cohort study, Serous fluid, Confidence interval, Carcinoma and Cohort in her Ovarian cancer study.
Her research in Oncology intersects with topics in Inflammation, Case-control study, Biomarker, Breast cancer and Risk factor.
The study incorporates disciplines such as Lower risk, Ovarian tumor and Endometrial cancer in addition to Prospective cohort study.
Between 2017 and 2021, her most popular works were:
- Shared heritability and functional enrichment across six solid cancers (41 citations)
- Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study. (41 citations)
- Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study. (41 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
Shelley S. Tworoger mostly deals with Internal medicine, Ovarian cancer, Oncology, Hazard ratio and Proportional hazards model.
Her research is interdisciplinary, bridging the disciplines of Type 2 diabetes and Internal medicine.
She has researched Ovarian cancer in several fields, including Cohort study, Lower risk, Serous fluid, Aspirin and Cohort.
Her Oncology research incorporates themes from Inflammation, Biomarker, Breast cancer, Cancer prevention and Risk factor.
Her Hazard ratio study incorporates themes from Body mass index, Nurses' Health Study, Obstructive sleep apnea and Obstetrics.
Her Prospective cohort study research is multidisciplinary, relying on both Psychological intervention and Marital status.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
